PharMerica Corp. (NYSE:PMC) shares traded down 2.5% on Thursday . The company traded as low as $24.88 and last traded at $24.94, with a volume of 419,408 shares traded. The stock had previously closed at $25.57.

A number of research analysts have recently weighed in on the stock. TheStreet cut shares of PharMerica Corp. from a “buy” rating to a “hold” rating in a research note on Monday, May 9th. Zacks Investment Research raised shares of PharMerica Corp. from a “hold” rating to a “strong-buy” rating and set a $30.00 price objective for the company in a research note on Thursday, May 12th. Barrington Research reissued an “outperform” rating and set a $34.00 price objective (up from $30.00) on shares of PharMerica Corp. in a research note on Tuesday, May 10th. Finally, Bank of America Corp. assumed coverage on shares of PharMerica Corp. in a research note on Tuesday, June 7th. They set a “buy” rating and a $32.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. PharMerica Corp. presently has a consensus rating of “Buy” and a consensus target price of $31.57.

The company has a 50 day moving average of $25.02 and a 200-day moving average of $24.64. The stock has a market capitalization of $758.95 million and a PE ratio of 25.49.

PharMerica Corp. (NYSE:PMC) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.47. The firm had revenue of $519.60 million for the quarter, compared to analyst estimates of $508.31 million. During the same quarter in the prior year, the firm earned $0.48 EPS. The firm’s revenue was up 4.4% compared to the same quarter last year. Equities analysts anticipate that PharMerica Corp. will post $2.01 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in PharMerica Corp. stock. Wells Fargo & Company MN increased its stake in shares of PharMerica Corp. (NYSE:PMC) by 3.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 305,474 shares of the company’s stock after buying an additional 10,609 shares during the period. Wells Fargo & Company MN owned approximately 1.00% of PharMerica Corp. worth $10,692,000 as of its most recent filing with the SEC.

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.